Viewing StudyNCT00205842



Ignite Creation Date: 2024-05-05 @ 12:00 PM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00205842
Status: COMPLETED
Last Update Posted: 2016-01-11
First Post: 2005-09-13

Brief Title: Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel DysfunctionPostoperative Ileus
Sponsor: Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Organization: Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA

Organization Data

Organization: Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Class: INDUSTRY
Study ID: 3753-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
GlaxoSmithKline INDUSTRY